NCT06805812 2025-02-03PALMARES-2Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruiting3,500 enrolled
NCT02586675 2022-01-21TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed7 enrolled 8 charts